Genetic Disorders

Bayer and Berkeley Lights embark on a project to automate drug discovery Pharmaceutical giant Bayer and Berkeley Lights have announced their collaboration to conduct a strategic project on a discovery platform aimed to automate antibody discovery and development of cell lines. Bayer and Berkeley Lights’ platform- Beacon- aims to automate biological processes in the drug development process. Merger between Rocket and Inotek bags Nasdaq listing, aims to conduct gene therapy trials Rocket Pharmaceuticals merged with Inotek through reverse merger process, and grabbed a NASDAQ listing in the process. The deal has now started the process of gene therapy research, and Inotek ...